Download the Schwab app from iTunes®Close

Insights & Ideas

Keeping you at the forefront of modern investing
CONTENT WITH Stocks
U.S. stocks finished higher as the S&P 500 registered a fresh record closing level in the last session of a volatile, holiday-shortened week. Investors tried to shake off omicron concerns as some studies suggested it may be less severe than its brethren, and following additional COVID-19 treatments which were granted U.S. Food and Drug Administration (FDA) emergency use authorization. Despite the ongoing concerns around omicron, inflation, and interest rates, some upbeat economic reports boosted stocks, as jobless claims remain near pre-pandemic lows, durable goods orders came in well above forecasts, consumer sentiment was revised higher, and new home sales hit a seven-month high. Treasuries were lower, lifting yields, and the U.S. dollar ticked lower, while crude oil and gold traded to the upside. In light equity news, Quidel Corp. agreed to purchase Ortho Clinical Diagnostics for $6 billion, and Merck's molnupiravir pill received FDA's emergency use authorization for treatment of mild-to-moderate coronavirus disease in adults. Asia and Europe finished broadly higher on the back of gains out of the U.S. yesterday, and as omicron concerns receded.
|
Despite the strong year for stocks in 2021, markets have confidently priced in some negative trends gathering more momentum in 2022 which may help markets, should trends reverse.
As we look to the new year, what can investors expect from the markets in 2022?
|
Will a chip shortage give way to oversupply?
|
Some of the market’s recent pressures are showing signs of easing.
|
Find out why you should have a trade plan—and the five elements that may help you put it to work successfully.
|
Schwab's views on the Communication Services sector.
|
Schwab's views on the Consumer Discretionary sector.
|
Schwab's views on the Consumer Staples sector.
|
Schwab's views on the Energy sector.
Thumbs up / down votes are submitted voluntarily by readers and are not meant to suggest the future performance or suitability of any account type, product or service for any particular reader and may not be representative of the experience of other readers. When displayed, thumbs up / down vote counts represent whether people found the content helpful or not helpful and are not intended as a testimonial. Any written feedback or comments collected on this page will not be published. Charles Schwab & Co., Inc. may in its sole discretion re-set the vote count to zero, remove votes appearing to be generated by robots or scripts, or remove the modules used to collect feedback and votes.